Madrigal Pharmaceuticals, Inc. Share Price
Stocks
MDGL
US5588681057
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 553.48 USD | +1.46% |
|
+3.13% | -4.96% |
| Market Cap | 1.28TCr 1.12TCr 1.03TCr 948.53Cr 1.79TCr 1,22900Cr 1.83TCr 12TCr 4.84TCr 60TCr 4.79TCr 4.69TCr 2,07200Cr | P/E 2026 * |
-77x | P/E 2027 * | 56.7x |
|---|---|---|---|---|---|
| Enterprise Value | 1.22TCr 1.07TCr 986.37Cr 909.19Cr 1.71TCr 1,17800Cr 1.75TCr 12TCr 4.64TCr 58TCr 4.59TCr 4.49TCr 1,98600Cr | EV / Sales 2026 * |
8.2x | EV / Sales 2027 * | 5.28x |
| Free-Float |
94.32% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Madrigal Pharmaceuticals, Inc.
| 1 day | +1.46% | ||
| 1 week | +3.13% | ||
| Current month | +3.08% | ||
| 1 month | +10.73% | ||
| 3 months | +4.03% | ||
| 6 months | +10.33% | ||
| Current year | -4.96% |
| 1 week | 522.7 |  | 560.08 |
| 1 month | 500.8 | | 569.44 |
| Current year | 416.21 | | 598.79 |
| 1 year | 286.44 | | 615 |
| 3 years | 119.76 | | 615 |
| 5 years | 52.33 | | 615 |
| 10 years | 6.6 | | 615 |
| Manager | Title | Age | Since |
|---|---|---|---|
William Sibold
CEO | Chief Executive Officer | 59 | 08/09/2023 |
Mardi Dier
DFI | Director of Finance/CFO | 62 | 11/03/2024 |
David Soergel
CTO | Chief Tech/Sci/R&D Officer | 58 | 21/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Rebecca Taub
BRD | Director/Board Member | 74 | 01/07/2016 |
Richard Levy
BRD | Director/Board Member | 68 | 11/08/2016 |
James Daly
BRD | Director/Board Member | 64 | 27/06/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 17/06/26 | Free | Director | 1,085 | 0.0047% | ||
| 17/06/26 | Free | Director | 1,220 | 0.0053% | ||
| 17/06/26 | Baker Bros. Advisors LP
| Free | Company | 4,880 | 0.0212% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.46% | +3.13% | +58.71% | +148.16% | 1.28TCr | |
| -7.17% | -4.39% | +45.51% | +79.00% | 5.21TCr | |
| +0.24% | -1.54% | +53.22% | +71.85% | 5.38TCr | |
| +0.80% | -6.31% | +3.98% | +423.29% | 2.35TCr | |
| -0.09% | -0.01% | -17.62% | -14.67% | 2.31TCr | |
| -5.95% | -2.58% | +30.67% | -9.58% | 1.94TCr | |
| -1.14% | +0.03% | +31.57% | -30.42% | 1.76TCr | |
| -5.16% | -7.00% | +168.44% | +306.37% | 1.52TCr | |
| -6.91% | -5.83% | +26.53% | +636.97% | 1.48TCr | |
| +0.43% | -1.03% | +24.63% | +191.40% | 1.41TCr | |
| Average | -2.35% | -2.05% | +42.57% | +180.24% | 2.46TCr | |
| Weighted average by Cap. | -2.58% | -2.07% | +41.08% | +144.32% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 149.17Cr 130.36Cr 120.29Cr 110.88Cr 208.99Cr 14TCr 213.62Cr 1.44TCr 565.51Cr 7.04TCr 560.2Cr 547.91Cr 24TCr | 220.96Cr 193.09Cr 178.18Cr 164.24Cr 309.56Cr 21TCr 316.43Cr 2.13TCr 837.67Cr 10TCr 829.8Cr 811.59Cr 36TCr |
| Net income | -21Cr -18Cr -17Cr -15Cr -29Cr -1.98TCr -29Cr -197.7Cr -78Cr -967.4Cr -77Cr -75Cr -3.33TCr | 31Cr 27Cr 25Cr 23Cr 43Cr 2.96TCr 44Cr 296.56Cr 116.64Cr 1.45TCr 115.55Cr 113.01Cr 5TCr |
| Net Debt | -53Cr -46Cr -43Cr -39Cr -74Cr -5.1TCr -76Cr -510.09Cr -200.63Cr -2.5TCr -198.75Cr -194.39Cr -8.59TCr | -109.47Cr -96Cr -88Cr -81Cr -153.37Cr -11TCr -156.77Cr -1.06TCr -415.01Cr -5.16TCr -411.11Cr -402.09Cr -18TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/26/17 | $553.48 | +1.46% | 5,28,309 |
| 16/26/16 | $545.53 | -0.86% | 2,38,337 |
| 15/26/15 | $550.25 | +2.49% | 2,64,309 |
| 14/26/14 | $536.86 | +1.10% | 2,41,715 |
| 13/26/13 | $531.00 | -1.06% | 2,87,887 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MDGL Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
